MedPath
NMPA Approval

Thymopentin for Injection

国药准字H20084025

November 28, 2022

国药准字H20084025

Drug Information

注射用胸腺五肽

注射剂

1mg

化学药品

November 28, 2022

Company Information

Applicant Company

海口国家高新区药谷工业园区药谷三横路2号

Manufacturing Company

海口国家高新区药谷工业园区药谷三横路2号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用胸腺五肽 - NMPA 批准文号 | MedPath